The diagnostic medicine company Alliar informed Friday evening that the Brazilian Securities Commission (CVM) did not accept the request for an additional period for its controlling shareholder to submit all the necessary documentation for the conduct of a public offering of share purchase (OPA). .
“The company will work with the bidder to obtain information regarding the measures that will be taken in the face of the refusal and the next steps,” Alliar said in a material fact, referring to Fonte de Saúde FIP Multiestratégia.
Source: Terra
Rose James is a Gossipify movie and series reviewer known for her in-depth analysis and unique perspective on the latest releases. With a background in film studies, she provides engaging and informative reviews, and keeps readers up to date with industry trends and emerging talents.
